This pathway was also observed in colon cancer cells treated with piperlongumine (Figure 4, Figure 5, Figure 6) and the downregulation of the NR4A1-regulated pro-reductant genes has not previously been observed in studies with piperlongumine. This evidence concerns the gene NR4A1 and colonic neoplasm.